Evaluation of a Training Program for Homozygous Sickle Cell Disease Patients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Sickle Cell Hemoglobin C DiseaseHemoglobin S Disease
Interventions
OTHER

Training Program

Each training session will last 45 min. Exercise will start by a 5-min warm-up cycling period, followed by 30 min of cycling at the power output (W) individually determined before and corresponding to the first lactate threshold corresponding approximately to 2.5 mmol/l . Then patients will cool down for 5 min. Finally, the training sessions will end by 5 min of light stretching. All training sessions will take place at the hospital and will be under the supervision of a physician. Heart rate, oxygen saturation and blood lactate concentrations will be regularly measured. Work rate will be adjusted according to the obtained results. As a safety procedure, blood lactate concentration must not exceed 4 mmol/L during the training sessions. A particular attention will be paid to the hydration of patients. Pain and fatigue will be evaluated everyday by the patients using (100 mm) visual analog scales.

Trial Locations (9)

42000

CHU de SAINT-ETIENNE, Saint-Etienne

75015

Hopital Europeen Georges POMPIDOU, Paris

Hopital Necker, Paris

75020

Hopital Tenon, Paris

91100

Centre hospitalier sud francilien, Corbeil-Essonnes

93000

Hopital Avicenne, Bobigny

93200

Centre hospitalier de Saint-Denis, Saint-Denis

93270

CHU Kremlin-Bicêtre, Le Kremlin-Bicêtre

94010

CHU Henri MONDOR, Créteil

All Listed Sponsors
collaborator

Centre de Référence des Syndromes Drépanocytaires Majeurs

OTHER

collaborator

Laboratoire de Physiologie de l'Exercice

UNKNOWN

collaborator

Claude Bernard University

OTHER

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02571088 - Evaluation of a Training Program for Homozygous Sickle Cell Disease Patients | Biotech Hunter | Biotech Hunter